2023 Form 5500 filing — Eagle Pharmaceuticals Inc 401(K) Profit Sharing Plan & Trust
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015160226NAL0030269585001) for Eagle Pharmaceuticals Inc 401(K) Profit Sharing Plan & Trust, reported by Eagle Pharmaceuticals Inc under EIN 20-8179278 and plan number 001. It reports 188 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015160226NAL0030269585001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Eagle Pharmaceuticals Inc
- EIN
- 20-8179278
- Plan number
- 001
- Location
- Woodcliff Lake, NJ
- Participants
- 188
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $15,913,040
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $15,913,040
- Employer contributions
- $1,177,502
- Participant contributions
- $2,572,058
- Total income / additions
- $6,649,218
- Benefits paid
- $3,670,874
- Administrative expenses
- $53,435
- Total expenses
- $3,727,539
- Net increase / (decrease)
- $2,921,679
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Merrill Lynch, Pierce, Fenner | INVESTMENT ADVISORY PLAN | $34,963 | not reported in the loaded dataset |
| Paychex, Inc. | RECORDKEEPER | $13,725 | not reported in the loaded dataset |